Just a moment, the page is loading...
Browse ALL STUDIES
Keyword Search
View All Selected
Clear All
Login / Create Account
Login
Create Account
Home
About Us
Privacy Policy
Minimum System Requirements
How To Join
Mission
Sponsors/Funders
How It Works
How to Request Data
Review of Requests
Data Sharing Agreement
Access to Data
Independent Review Panel
Metrics
FAQs
News
Help/Contact Us
ASTELLAS-015K-CL-RAJ1
Study Sponsor:
Astellas
Study Title
Phase 2b Study of ASP015K – A Double-Blind, Placebo-Controlled, Dose-Finding Study in Moderate to Severe Rheumatoid Arthritis Patients –
Medicine or Vaccine (generic name)
peficitinib hydrobromide
Sponsor Identification Number
015K-CL-RAJ1
Trial Registry Identification Number(#'s)
NCT01649999
Medical Condition
Rheumatoid Arthritis
Phase
Phase 2
Link to Astellas Study Register
https://astellasclinicalstudyresults.com/hcp/study.aspx?ID=334
Link to study details on ClinicalTrials.gov (if available)
https://clinicaltrials.gov/ct2/show/NCT01649999
Link to study details on EudraCT (if available)
Datasets and Documents Available for this Study
Raw dataset
Annotated case report form
Dataset specifications
Protocol with any amendments
Analysis-ready dataset
Reporting and analysis plan
Clinical study report
Ready to Share
Additional information about the data and documents available for this study
Date Added to this Site
July 2020
© 2021 ideaPoint. All Rights Reserved.
Powered by ideaPoint.
Help
Privacy Policy
Cookie Policy
Help and Resources